GPT and metabolic dysfunction-associated steatotic liver disease: Currently, the therapy for NAFLD is weight reduction, which successfully reduces liver fat and biomarkers of hepatic injury such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) [14].